Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02799095
Title A Study of the Effects of ALKS 4230 on Subjects With Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alkermes, Inc.
Indications

ovarian cancer

Advanced Solid Tumor

renal cell carcinoma

melanoma

Therapies

ALKS 4230

Age Groups: adult
Covered Countries USA | ESP | CAN | BEL

Facility Status City State Zip Country Details
Alkermes Investigational Site Denver Colorado 80045 United States Details
Alkermes Investigational Site Port Saint Lucie Florida 34952 United States Details
Alkermes Investigational Site Tampa Florida 33610 United States Details
Alkermes Investigational Site Lexington Kentucky 40536 United States Details
Alkermes Investigational Site Boston Massachusetts 02215 United States Details
Alkermes Investigational Site Detroit Michigan 47201 United States Details
Alkermes Investigational Site Buffalo New York 14203 United States Details
Alkermes Investigational Site New York New York 10016 United States Details
Alkermes Investigational Site Cleveland Ohio 44106 United States Details
Alkermes Investigational Site Dallas Texas 75230 United States Details
Alkermes Investigational Site Fairfax Virginia 22031 United States Details
Alkermes Investigational Site Spokane Washington 99208 United States Details
Alkermes Investgational Site Albury New South Wales 2640 Australia Details
Alkermes Investigational Site Waratah New South Wales 2298 Australia Details
Alkermes Investigational Site Brussels MO 1200 Belgium Details
Alkermes Investigational Site Kortrijk West-Vlaanderen 8500 Belgium Details
Alkermes Investigational Site Edmonton Alberta Canada Details
Alkermes Investigational Site Hamilton Ontario Canada Details
Alkermes Investigational Site Toronto Ontario Canada Details
Alkermes Investigational Site Montréal Quebec Canada Details
Alkermes Investigational Site Québec Quebec G1R 2J6 Canada Details
Alkermes Investigational Site Daejeon 35015 Korea, Republic of Details
Alkermes Investigational Site Seoul 02841 Korea, Republic of Details
Alkermes Investigational Site Seoul 03722 Korea, Republic of Details
Alkermes Investigational Site Skorzewo Poznan 60-185 Poland Details
Alkermes Investigational Site Barcelona 8036 Spain Details
Alkermes Investigational Site Madrid 28033 Spain Details
Alkermes Investigational Site Madrid 28040 Spain Details
Alkermes Investigational Site Madrid 28041 Spain Details
Alkermes Investigational Site Madrid 28050 Spain Details
Alkermes Investigational Site Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field